Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pluristem seeks German approval to initiate ischemia study
Assuming approval of the investigational medicinal product dossier (IMPD) by this authority, Pluristem plans to initiate the dose ranging clinical trial during the second quarter of 2009 at
Assuming approval of the investigational medicinal product dossier (IMPD) by this authority, Pluristem plans to initiate the dose ranging clinical trial during the second quarter of 2009 at
Together, the companies will launch a series of products with ELASTIderm’s technology into consumer sales and distribution channels in Japan, including premium retail distribution channels, as well as
Based on input received at the pre-new drug submission (NDS) meeting, the company believes that no additional pivotal clinical data beyond that which was submitted as part of
As part of the restructuring and in order to further reduce costs, president and CEO, James Burns, will be leaving the company and resigning from the board of
According to the company, the new Diazyme lithium assay provides improved reagent stability and a reduced cost per test. The assay features accuracy and precision and offers an
According to the company, Embozene microspheres are the first and only microspheres to be color-enhanced with a different color for each size for increased procedural safety, efficiency and
The company presented data from the Phase II trial of BSI-201 in metastatic breast cancer patients whose tumors were negative for three common breast cancer markers: estrogen receptor,
AmVac and the National Health Research Institutes in Taiwan have resolved to launch a joint collaboration with the aim of developing a new avian flu vaccine. The Taiwanese
Abraxane is an albumin-bound nanoparticle formulation of paclitaxel. In the European Union (EU), Abraxane is indicated for the treatment of metastatic breast cancer in patients who have failed
The investment includes the purchase of 100,000sqft of land adjacent to the current facility where the company intends to make further upgrades in the next three years. The